How Much Does Immunotherapy Cost in Italy?
Immunotherapy in Italy typically costs from $6,500 to $13,000. The total price depends on the drug protocol, cancer type, and the number of treatment cycles required. Patients save approximately 66% compared to the United States, where the average cost is $28,500. Basic immunotherapy fees usually cover the drug administration and initial specialist consultations.
- Immunotherapy with Keytruda (Pembolizumab): $4,300 to $6,700 for advanced monoclonal antibody protocols.
- Bacillus Calmette-Guérin (BCG) therapy: $2,500 to $4,500 for localized bladder cancer treatments.
- CAR T-cell therapy: Price on request to Price on request for complex cellular engineering treatments.
- Specialist consultations: Private oncological visits in Milan typically cost between 15% and 20% more than in regional hubs.
Bookimed Expert Insight: Milan serves as the primary hub for advanced oncology. San Raffaele Hospital treats over 12,000 cancer patients annually. It offers access to PET-MRI and three da Vinci robots. Choosing IRCCS-accredited facilities ensures treatment at top-tier research centers. San Donato Hospital provides packages starting around $2,100. These include on-site hotel stays for international families. This integration reduces logistics costs during long-term therapy cycles.
| Italy | Turkey | Austria | |
|---|---|---|---|
| Immunotherapy | ≈ $6,500 | from $2,500 | ≈ $9,000 |
| Sarcoma Immunotherapy | ≈ $14,000 | from $8,900 | ≈ $18,000 |
| Immunotherapy for prostate cancer | ≈ $50,000 | from $8,000 | ≈ $9,500 |
| Immunotherapy for lung cancer | ≈ $14,000 | from $8,000 | ≈ $30,000 |
| Immunotherapy for kidney cancer | ≈ $18,000 | from $8,000 | ≈ $28,000 |
Your Benefits and Guarantees with Bookimed
Transparent Prices & Flexible Installments
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy upon arrival and use a flexible installment plan if needed.
Verified Clinics & Doctors Only
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy and have the necessary licenses to serve international patients worldwide.
Free 24/7 Assistance
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy journey.

Your personal Bookimed medical coordinator
- Supports you at every stage
- Helps choose the right clinic and doctor
- Ensures quick and convenient access to information
Discover the Best Immunotherapy Clinics in Italy: 2 Verified Options and Prices
Immunotherapy Overview in Italy
Day 1
- Arrive in the country and transfer to the hotel.
- Rest and adjust to the new environment.
Day 2
- Transfer to the clinic.
- Consultation with specialists about your medical history and current health condition.
- Perform necessary medical tests like blood tests, allergy tests, etc.
Day 3
- Discussion about the results of your medical tests.
- Plan and schedule your immunotherapy treatment.
Day 4
- Start of your immunotherapy treatment.
- The process lasts for about 2-3 hours without the need for anesthesia.
- Observe your reaction to the treatment under medical supervision.
Day 5 to Day 7
- Continue with your immunotherapy sessions as scheduled.
- Regular monitoring of your condition by the medical team.
Week 2
- Completion of your immunotherapy treatment.
- Post-treatment consultation and guidelines.
- Transfer back to the hotel.
Week 3
- Recovery period at the hotel.
- Gradual return to daily activities.
Week 4
- Check out from the hotel.
- Transfer to the airport for departure.
Please note that each patient"s case is unique and the above schedule can change depending on the patient"s health condition and response to the treatment.
- Bookimed deposit: $200 or €200.
- Clinic deposit: Pay a set percentage in advance.
Video Stories from Bookimed Patients
Reviews about Bookimed: Discover Patients' Insights
All reviews



Related Articles

Immunotherapy for Cancer Cost: Global Comparison 2026
Written by Kateryna Zamkovska
Share this content
Anna Leonova
Our Immunotherapy Techniques: What Suits You Best?
When considering Immunotherapy, it’s important to understand the different techniques and which is best suited for you. Here’s a concise comparison of popular options:

Immunotherapy with Keytruda (Pembolizumab)
Keytruda, a form of immune-based therapy, leverages the body's immune system to target and destroy cancer cells using monoclonal antibodies.
FAQ about Immunotherapy in Italy
What types of immunotherapy treatments are available in Italy?
Immunotherapy treatments in Italy include immune checkpoint inhibitors like pembrolizumab and nivolumab, CAR-T cell therapy, and sublingual immunotherapy for allergies. These therapies are regulated by the Italian Medicines Agency and available at accredited centers like San Raffaele in Milan for oncology and hematology.
- Checkpoint inhibitors: Block proteins like PD-1 or CTLA-4 to help T-cells attack solid tumors.
- CAR-T therapy: Re-engineers patient T-cells in labs to destroy specific leukemia or lymphoma cells.
- Biological therapy: Uses monoclonal antibodies to target antigens and block cancer growth signals.
- Experimental trials: Research centers offer clinical trials for dendritic-cell vaccines and combination regimens.
Bookimed Expert Insight: While many countries focus solely on cancer, Italy is a leader in diverse immunotherapy applications. San Raffaele in Milan, for instance, performed the first stem cell therapy for severe combined immune deficiency. This highlights Italy's expertise in cellular immunotherapy beyond standard oncology protocols.
Patient Consensus: Patients emphasize the importance of distinguishing between short-term allergy tablets and long-term cancer protocols. Monitoring for delayed side effects like fatigue or liver enzyme changes is a common practical concern during extended treatment cycles.
What is the current status of immunotherapy in Italy's healthcare system?
Immunotherapy is fully integrated into Italy's universal healthcare system and routinely reimbursed for regulatory-approved oncological indications. The Italian Medicines Agency centrally regulates and funds advanced treatments like immune checkpoint inhibitors and cellular therapies within standard public oncology care.
- Central regulation: The Italian Medicines Agency evaluates and approves clinical reimbursement nationwide.
- Modern framework: Assessments prioritize comparative effectiveness and budget impact under European Union alignment.
- Regional delivery: Practical access and waiting times vary between regional hospital networks.
- Specialized hubs: Scientific research institutes like San Raffaele manage complex oncology cases.
Bookimed Expert Insight: Patient volume data highlights a strategic pathway for navigating the public system. Major research hubs in Milan like San Raffaele treat 12,000 cancer patients annually. Choosing an institute with scientific accreditation speeds up access to modern biological therapies.
Patient Consensus: The public healthcare system covers expensive modern therapies at no cost after specialist referral. However, patients advise booking a private consultation with a public-system doctor to bypass regional waiting times.
Are treatments covered under Italy's public healthcare system (SSN)?
Italy's Servizio Sanitario Nazionale (SSN) covers immunotherapy and other expensive cancer treatments for registered residents. These Essential Levels of Care (LEA) are generally free at public or accredited private hospitals. Patients typically only pay a small copayment, known as a ticket, for diagnostic tests or specialist consultations.
- Eligibility criteria: Access requires formal residency status and registration with the national health system.
- Access pathway: Patients need a general practitioner referral to consult an oncology specialist.
- Medication coverage: Essential drugs, including high-cost Class A therapies, are free or heavily subsidized.
- Chronic exemptions: Patients with registered cancer diagnoses are often exempt from standard regional copayments.
Bookimed Expert Insight: While the public system covers high-cost drugs like Keytruda, international patients often choose Milanese centers like San Raffaele for faster access to clinical trials. This clinic achieved the world's first stem cell therapy for severe immune deficiency. Public coverage is medically robust but navigating the paperwork takes time, making private oncology consultations a common way to speed up the initial diagnostic phase.
Patient Consensus: The public system provides excellent care for serious illnesses, though the administrative process can be slow. Residents suggest keeping tax codes and residency papers ready to avoid delays in starting life-saving treatments.
How can a patient access clinical trials for immunotherapy in Italy?
Accessing immunotherapy clinical trials in Italy requires a referral to a certified Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) center. Patients must consult an oncologist to verify eligibility against strict inclusion criteria like PD-L1 expression before searching official registries like the EU Clinical Trials Information System.
- Specialist consultation: Your oncologist must formally refer your records to the trial principal investigator.
- Registry search: Use the EU Clinical Trials Register or ClinicalTrials.gov to find Italian sites.
- IRCCS centers: Specialized hospitals like San Raffaele in Milan manage advanced cellular therapy protocols.
- Regulatory oversight: The Italian Medicines Agency (AIFA) maintains maps of active experimental trial sites.
Bookimed Expert Insight: While many search globally, Italy stands out for specialized cellular therapies at IRCCS centers like San Raffaele. Data shows these facilities serve 300,000 patients annually and pioneered the world's first stem cell therapy for immune deficiency. Choosing a center with these specific credentials often indicates a stronger infrastructure for managing complex, late-stage immune reactions.
Patient Consensus: Patients emphasize that access depends on finding the exact National Clinical Trial ID rather than just the drug name. Success often involves checking if the research center accepts outside referrals early in the process.




